0001485003-20-000026.txt : 20200226
0001485003-20-000026.hdr.sgml : 20200226
20200226172113
ACCESSION NUMBER: 0001485003-20-000026
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200224
FILED AS OF DATE: 20200226
DATE AS OF CHANGE: 20200226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bourdow Carrie L.
CENTRAL INDEX KEY: 0001638989
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36296
FILM NUMBER: 20657212
MAIL ADDRESS:
STREET 1: C/O TREVENA, INC.
STREET 2: 1018 WEST 8TH AVENUE, SUITE A
CITY: KING OF PRUSSIA
STATE: PA
ZIP: 19406
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sesen Bio, Inc.
CENTRAL INDEX KEY: 0001485003
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 262025616
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 245 FIRST STREET
STREET 2: SUITE 1800
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-444-8550
MAIL ADDRESS:
STREET 1: 245 FIRST STREET
STREET 2: SUITE 1800
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Eleven Biotherapeutics, Inc.
DATE OF NAME CHANGE: 20100223
4
1
wf-form4_158275565627269.xml
FORM 4
X0306
4
2020-02-24
0
0001485003
Sesen Bio, Inc.
SESN
0001638989
Bourdow Carrie L.
C/O SESEN BIO, INC.
245 FIRST STREET, SUITE 1800
CAMBRIDGE
MA
02142
1
0
0
0
Stock Option
0.8224
2020-02-24
4
A
0
118000
0
A
2030-02-24
Common Stock
118000.0
118000
D
The option was granted on February 24, 2020 and vests monthly in equal amounts over a three-year period following the grant date.
/s/ Mark R. Sullivan, as attorney-in-fact
2020-02-26